- Home
- MNKD vs BST Comparison
MNKD vs BST Comparison
Compare MNKD & BST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- BST
- Stock Information
- Founded
- MNKD 1991
- BST 2014
- Country
- MNKD United States
- BST United States
- Employees
- MNKD N/A
- BST N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- BST Finance Companies
- Sector
- MNKD Health Care
- BST Finance
- Exchange
- MNKD Nasdaq
- BST Nasdaq
- Market Cap
- MNKD 1.7B
- BST 1.4B
- IPO Year
- MNKD 2004
- BST N/A
- Fundamental
- Price
- MNKD $5.72
- BST $42.04
- Analyst Decision
- MNKD Strong Buy
- BST
- Analyst Count
- MNKD 5
- BST 0
- Target Price
- MNKD $10.80
- BST N/A
- AVG Volume (30 Days)
- MNKD 3.8M
- BST 96.3K
- Earning Date
- MNKD 11-06-2025
- BST 01-01-0001
- Dividend Yield
- MNKD N/A
- BST 7.13%
- EPS Growth
- MNKD 149.32
- BST N/A
- EPS
- MNKD 0.11
- BST N/A
- Revenue
- MNKD $301,736,000.00
- BST N/A
- Revenue This Year
- MNKD $16.36
- BST N/A
- Revenue Next Year
- MNKD $20.34
- BST N/A
- P/E Ratio
- MNKD $52.68
- BST N/A
- Revenue Growth
- MNKD 21.48
- BST N/A
- 52 Week Low
- MNKD $3.38
- BST $27.87
- 52 Week High
- MNKD $7.63
- BST $42.40
- Technical
- Relative Strength Index (RSI)
- MNKD 63.58
- BST 71.38
- Support Level
- MNKD $5.33
- BST $41.52
- Resistance Level
- MNKD $5.90
- BST $41.64
- Average True Range (ATR)
- MNKD 0.21
- BST 0.43
- MACD
- MNKD -0.02
- BST 0.05
- Stochastic Oscillator
- MNKD 77.46
- BST 78.00
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About BST BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.